- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/14 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/14
Total number of patents in this class: 506
10-year publication summary
|
22
|
23
|
23
|
34
|
36
|
36
|
34
|
31
|
38
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5815 |
20 |
| Bristol-myers Squibb Company | 4880 |
18 |
| Agios Pharmaceuticals, Inc | 216 |
17 |
| Newave Pharmaceutical Inc. | 69 |
16 |
| Janssen Pharmaceutica N.V. | 3394 |
10 |
| BASF SE | 20940 |
9 |
| Senhwa Biosciences, Inc. | 38 |
9 |
| Shionogi & Co., Ltd. | 852 |
8 |
| Abbvie Inc. | 1800 |
7 |
| Rigel Pharmaceuticals, Inc. | 538 |
7 |
| Anima Biotech Inc. | 38 |
7 |
| Novartis AG | 10744 |
6 |
| Genentech, Inc. | 3976 |
6 |
| Istituto Nazionale di Genetica Molecolare-ingm | 24 |
6 |
| Janssen Sciences Ireland UC | 183 |
6 |
| Ospedale San Raffaele S.r.l. | 277 |
6 |
| Irbm S.p.A. | 23 |
6 |
| Iteos Belgium SA | 43 |
6 |
| Pfizer Inc. | 3371 |
5 |
| FUJIFILM Corporation | 29437 |
5 |
| Other owners | 326 |